TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
VERU
Veru
$
()
VERU
Veru initiated with bullish view at Raymond James, here's why
VERU
3/27/2024 - 16:19pm
Veru appoints Louis Arrone as chief medical advisor for Enobosarm program
VERU
3/12/2024 - 08:17am
Veru receives Nasdaq notification on delayed quarterly report
VERU
2/27/2024 - 19:16pm
Veru announces new scientific advisory board for enobosarm program
VERU
2/20/2024 - 08:45am
Veru reports Q1 revenue $2.1M vs. $2.5M last year
VERU
2/8/2024 - 07:21am
Veru announces FDA clearance of IND application for Phase 2b with enobosarm
VERU
2/6/2024 - 08:34am
Veru submits IND application to FDA for development of enobosarm
VERU
1/8/2024 - 08:43am
Veru to host investor call to discuss financing, enobosarm strategy
VERU
12/19/2023 - 08:34am
Veru prices 45.8M shares at 72c in underwritten public offering
VERU
12/14/2023 - 09:09am
Veru $25M Spot Secondary re-offered at 72c
VERU
12/13/2023 - 16:22pm
Veru files to sell common stock, no amount given
VERU
12/13/2023 - 16:02pm
Veru management to meet virtually with Jefferies
VERU
10/26/2023 - 13:26pm
Veru reports muscle data from five studies of enobosarm
VERU
10/4/2023 - 08:38am
Veru reaches agreement with FDA on Phase 3 trial for sabizabulin
VERU
9/26/2023 - 08:41am
Veru reports clinical data from discontinued ARTEST study
VERU
9/11/2023 - 07:06am
dynamic_feed
Breaking News
search
Search
menu
Menu